Mark Reisman, M.D.
Interventional Cardiologist and Director of the Cardiac Catheterization Lab, Swedish Heart & Vascular Institute
Mark Reisman, M.D., is an interventional cardiologist with the Swedish Heart & Vascular Institute in Seattle where he is also director of Swedish’s Cardiac Catheterization Lab on the Cherry Hill campus. In addition, he is a partner with Seattle Heart and Vascular Consultants.
Since joining Swedish's medical staff in 1995, Dr. Reisman has been principal investigator on dozens of clinical trials.
In addition to his clinical trial work, he has been a national leader in the commercial use of several medical devices that he and his fellow Swedish Heart & Vascular Institute interventional cardiologists helped investigate at the medical center. Two of these devices are Rotablator (a diamond-tipped device attached to a catheter and used like a tiny drill to break up blockages in coronary arteries) and the Beta-Cath System (a catheter-based device that uses tiny radioactive seeds to help ensure that coronary renarrow where stents are placed). In fact, Dr. Reisman’s pioneering work with Rotablator led him to write a book (Guide to Rotational Atherectomy; Physicians’ Press, 1997) about it. As a result, he has taught the procedure to hundreds of physicians worldwide. More recently, his work in investigating the Beta-Cath System allowed him to be one of the first interventional cardiologists in the country to use the device early during its clinical trials and subsequently the first physician in the country to use the device after it received FDA approval.
He has also played a key role in the Swedish Heart & Vascular Institute’s efforts to take a look at other exciting technologies for opening arteries and keeping them open, such as drug-coated cardiac stents as well as new drug-delivery systems. Dr. Reisman is also renowned for his pioneering work in the developing field of neurocardiovascular interventions for the treatment and prevention of strokes.
Board-certified in cardiology, Dr. Reisman has an additional certification in internal medicine.
He earned his bachelor’s degree from State University of New York at Stonybrook and his medical degree from Sackler School of Medicine’s New York State program. Dr. Reisman then did a one-year internship in internal medicine at Robert Wood Johnson Hospital in New Brunswick, N.J., followed by a two-year residency in internal medicine and a two-year fellowship in cardiology at St. Luke’s Roosevelt Hospital in New York, N.Y. Most recently, he completed a fellowship in interventional cardiology from University of California San Diego Medical Center.
Besides his roles at Swedish, Dr. Reisman has been a clinical assistant professor of medicine at the University of Washington since 1995. He is also co-chairman of the Clinical Outcomes Assessment Program of Washington state.
If you are a member of the news media and would like to speak with Dr. Reisman, contact Ed Boyle in Swedish's Corporate Communications Department at 206-386-2748 or via firstname.lastname@example.org